Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
55.4
64
|
Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC stock under the Base Case scenario is 41.57 SAR. Compared to the current market price of 58.2 SAR, Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Balance Sheet Decomposition
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Current Assets | 2.3B |
Cash & Short-Term Investments | 788.9m |
Receivables | 1.1B |
Other Current Assets | 396.9m |
Non-Current Assets | 2.9B |
Long-Term Investments | 438.1k |
PP&E | 2.2B |
Intangibles | 543m |
Other Non-Current Assets | 160.8m |
Current Liabilities | 613.9m |
Accounts Payable | 381.9m |
Accrued Liabilities | 177.5m |
Other Current Liabilities | 54.5m |
Non-Current Liabilities | 1.8B |
Long-Term Debt | 1.2B |
Other Non-Current Liabilities | 519m |
Earnings Waterfall
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Revenue
|
3.7B
SAR
|
Cost of Revenue
|
-2.7B
SAR
|
Gross Profit
|
967.1m
SAR
|
Operating Expenses
|
-439.2m
SAR
|
Operating Income
|
528m
SAR
|
Other Expenses
|
-128.2m
SAR
|
Net Income
|
399.8m
SAR
|
Free Cash Flow Analysis
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAR | |
Free Cash Flow | SAR |
Profitability Score
Profitability Due Diligence
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
According to Wall Street analysts, the average 1-year price target for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is 65.74 SAR with a low forecast of 61.61 SAR and a high forecast of 69.3 SAR.
Dividends
Current shareholder yield for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is a SA-based company operating in Health Care Providers & Services industry. The company is headquartered in Jeddah, Makkah. The company went IPO on 2024-06-05. Dr. Soliman Fakeeh Hospital (DSFH) is a Saudi Arabia-based company. The firm is engaged in operating private hospitals and clinics. The company offers its medical services through six units: the Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.
Contact
IPO
Employees
Officers
The intrinsic value of one Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC stock under the Base Case scenario is 41.57 SAR.
Compared to the current market price of 58.2 SAR, Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is Overvalued by 29%.